Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Garden balsam + platycladus orientalis leaves decoction is a traditional Chinese medicine (TCM) preparation utilized by the Jiaxing Hospital of Chinese Medicine for the treatment of androgenic alopecia (AGA). The decoction is composed of the aerial parts of *Impatiens balsamina* (garden balsam) and the leaves of *Platycladus orientalis* (oriental arborvitae). It is typically administered as a topical wash or soak to the scalp. The therapeutic effect is attributed to the synergistic action of phytochemicals such as naphthoquinones (e.g., lawsone) from garden balsam and flavonoids (e.g., quercitrin) from *Platycladus orientalis*. These constituents are thought to inhibit the activity of 5-alpha reductase, thereby reducing the conversion of testosterone to dihydrotestosterone (DHT), a primary driver of hair follicle miniaturization in AGA. Additionally, the preparation exhibits anti-inflammatory and antioxidant properties that support hair follicle health and stimulate the transition of follicles from the telogen to the anagen growth phase.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on garden balsam + platycladus orientalis leaves decoction.